微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 46.05% | -18.99% | 5.16% | 37/55 | 56.48% | 荣昌生物 | 95.71% | 行业排名> |
| 2026-03-31 | 43.79% | -27.13% | -13.89% | 37/55 | 60.48% | 我武生物 | 95.25% | 行业排名> |
| 2025-12-31 | 50.85% | -4.11% | -6.82% | 36/55 | 65.25% | 我武生物 | 95.24% | 行业排名> |
| 2025-09-30 | 54.57% | -5.02% | -4% | 36/55 | 66.5% | 我武生物 | 95.37% | 行业排名> |
| 2025-06-30 | 56.84% | -5.2% | -5.41% | 37/55 | 67.83% | 我武生物 | 95.1% | 行业排名> |
| 2025-03-31 | 60.09% | -8.96% | 13.32% | 36/55 | 36.56% | 金迪克 | 95.24% | 行业排名> |
| 2024-12-31 | 53.03% | -9.89% | -7.7% | 40/55 | 67.21% | 我武生物 | 95.16% | 行业排名> |
| 2024-09-30 | 57.45% | -2.34% | -4.19% | 37/55 | 69.22% | 我武生物 | 95.26% | 行业排名> |
| 2024-06-30 | 59.96% | -2.72% | -9.16% | 36/55 | 68.29% | 西藏药业 | 95.7% | 行业排名> |
| 2024-03-31 | 66.01% | 0.86% | 12.17% | 34/55 | 69.14% | 康华生物 | 96.08% | 行业排名> |
| 2023-12-31 | 58.85% | -8.01% | 0.03% | 34/55 | 67.71% | 我武生物 | 95.26% | 行业排名> |
| 2023-09-30 | 58.83% | -11.88% | -4.56% | 34/55 | 67.65% | 我武生物 | 95.4% | 行业排名> |
| 2023-06-30 | 61.64% | -7.93% | -5.81% | 33/55 | 62.76% | 华兰疫苗 | 101.02% | 行业排名> |
| 2023-03-31 | 65.44% | 2% | 2.31% | 33/55 | 69.01% | 华兰疫苗 | 100.22% | 行业排名> |
| 2022-12-31 | 63.97% | 6.82% | -4.18% | 33/55 | 67.1% | 我武生物 | 95.39% | 行业排名> |
| 2022-09-30 | 66.76% | 5.69% | -0.28% | 31/55 | 70.88% | 我武生物 | 95.63% | 行业排名> |
| 2022-06-30 | 66.94% | 2% | 11.79% | 34/55 | 68.78% | 我武生物 | 95.75% | 行业排名> |
| 2021-12-31 | 59.88% | 30.2% | -5.19% | 36/55 | 71.82% | 华兰疫苗 | 98.39% | 行业排名> |
| 2021-09-30 | 63.16% | 2% | 37.34% | 34/55 | 73.6% | 百奥泰 | 95.74% | 行业排名> |
| 2020-12-31 | 45.99% | 2% | 2% | 40/55 | 71.4% | 我武生物 | 95.89% | 行业排名> |